Sabby Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,189,700
| Closed | -$10.2M | – | 139 |
|
|
2021
Q4 | $10.2M | Buy |
2,189,700
+491,593
| +29% | +$2.29M | 1.48% | 5 |
|
|
2021
Q3 | $13M | Buy |
1,698,107
+500,131
| +42% | +$3.82M | 1.75% | 4 |
|
|
2021
Q2 | $11.6M | Buy |
1,197,976
+133,043
| +12% | +$1.29M | 1.64% | 2 |
|
|
2021
Q1 | $8.81M | Buy |
+1,064,933
| New | +$8.81M | 1.71% | 1 |
|
|
2020
Q4 | – | Sell |
-606,298
| Closed | -$6.76M | – | 116 |
|
|
2020
Q3 | $6.76M | Buy |
+606,298
| New | +$6.76M | 1.01% | 4 |
|
|
2020
Q2 | – | Sell |
-287,386
| Closed | -$529K | – | 93 |
|
|
2020
Q1 | $529K | Buy |
287,386
+260,208
| +957% | +$479K | 0.22% | 20 |
|
|
2019
Q4 | $92K | Buy |
+27,178
| New | +$92K | 0.03% | 43 |
|
|
2019
Q1 | – | Sell |
-84,536
| Closed | – | – | 112 |
|
|
2018
Q4 | $0 | Buy |
+84,536
| New | – | ﹤0.01% | 117 |
|
|
2017
Q3 | – | Sell |
-17,300
| Closed | -$35K | – | 150 |
|
|
2017
Q2 | $35K | Buy |
+17,300
| New | +$35K | ﹤0.01% | 105 |
|
|
2016
Q4 | – | Sell |
-20,986
| Closed | -$162K | – | 218 |
|
|
2016
Q3 | $162K | Sell |
20,986
-232,819
| -92% | -$1.8M | 0.01% | 128 |
|
|
2016
Q2 | $1.42M | Sell |
253,805
-125,995
| -33% | -$705K | 0.07% | 54 |
|
|
2016
Q1 | $2.04M | Buy |
379,800
+79,800
| +27% | +$429K | 0.1% | 45 |
|
|
2015
Q4 | $2.61M | Buy |
300,000
+132,936
| +80% | +$1.16M | 0.14% | 30 |
|
|
2015
Q3 | $1.4M | Buy |
+167,064
| New | +$1.4M | 0.06% | 88 |
|
|
2014
Q1 | – | Sell |
-222,026
| Closed | -$1.8M | – | 143 |
|
|
2013
Q4 | $1.8M | Buy |
+222,026
| New | +$1.8M | 0.11% | 28 |
|